Home LiteratureArticle Details
PMID: 3525407 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Infection and immunity ·Vol. 53 ·No. 2 ·1986-08-00 ·Pages 298-304

Fenwick BW, Cullor JS, Osburn BI, Olander HJ

Abstract

In an investigation of the potential protective effects of immunity against common lipopolysaccharide core antigens of gram-negative bacteria during a severe gram-negative infection in the natural host, we induced Haemophilus pleuropneumoniae infections in weanling pigs immunized with a vaccine of an Rc mutant of Escherichia coli (strain J5). To help define the mechanism involved in J5-mediated protection, we compared the clinical, hematologic, bacteriologic, and serologic responses following an H. pleuropneumoniae infection in J5-immunized pigs with those following an H. pleuropneumoniae infection in nonimmunized control animals. As a result of an intranasal inoculation, all of the control animals and the J5-immunized animals were infected with H. pleuropneumoniae. However, while 80% (4 of 5) of the nonimmunized pigs died within 24 h as a result of the infection, no deaths occurred in the J5-immunized animals. In the immunized group, J5 titers dropped during the acute stages of the infection and rebounded to well above the prechallenge levels during convalescence. The J5 titer also increased in the single surviving control animal. These findings suggest that antibodies against common subsurface components of gram-negative bacterial cell walls correlate with protection from an otherwise lethal challenge of H. pleuropneumoniae but do not prevent infection. Important growth-phase-dependent antigenic changes have been recognized to occur during the growth of H. pleuropneumoniae in cultures (R. Nielson, Nord. Veterinaermed. 28:337-348, 1976). In a study of these changes and during an inquiry into the mechanism of J5 antibody-mediated protection, measured quantities of H. pleuropneumoniae were removed from a broth culture at hourly intervals and used to absorb hyperimmune equine J5 antiserum. Significantly greater amounts of J5-specific antibodies were absorbed during the log phase of bacterial growth than during the early or late phase. The availability of epitopes recognized by J5 antibodies appears to be closely related to the rate of bacterial multiplication. The results of these experiments suggest a mechanism of protection provided by increased immunity to E. coli J5 during gram-negative infections.

MeSH Terms
Animals Antibodies, Bacterial/analysis Anticoagulants/therapeutic use Escherichia coli/immunology Haemophilus Infections/immunology,veterinary Immune Sera/immunology Immunization/veterinary Lipopolysaccharides/immunology Pneumonia/etiology,veterinary Swine Swine Diseases/immunology Temperature Thrombosis/etiology,veterinary
Chemicals
Antibodies, Bacterial Anticoagulants Immune Sera Lipopolysaccharides
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Fenwick B W
Cullor J S
Osburn B I
Olander H J
References (30)
30 references, click to expand
  1. A proposed mechanism for natural immunity to enterobacterial pathogens.
    J Immunol. 1968 Feb;100(2):292-306 PMID: 4867488
  2. THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT.
    J Biol Chem. 1965 May;240:1919-25 PMID: 14299610
  3. Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
    J Immunol. 1972 Mar;108(3):601-10 PMID: 4622185
  4. Passive immunization against the local Shwartzman reaction.
    J Immunol. 1972 Feb;108(2):505-12 PMID: 4558866
  5. The plasma protamine paracoagulation test: clinical and laboratory evaluation.
    Am J Clin Pathol. 1972 Dec;58(6):675-86 PMID: 4641163
  6. [Haemophilus-pleuropneumonia in swine. V. Pathomorphology].
    Schweiz Arch Tierheilkd. 1973 May;115(5):191-203 PMID: 4704798
  7. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
    J Immunol. 1973 Aug;111(2):433-8 PMID: 4577881
  8. Treatment and prevention of intravascular coagulation with antiserum to endotoxin.
    J Infect Dis. 1973 Jul;128:Suppl:157-64 PMID: 4578307
  9. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    J Exp Med. 1974 Sep 1;140(3):797-811 PMID: 4378413
  10. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.
    Trans Assoc Am Physicians. 1975;88:101-8 PMID: 772922
  11. Changes in intra-vascular complement and anti-treponemal antibody titres preceding the Jarisch-Herxheimer reaction in secondary syphilis.
    Clin Exp Immunol. 1976 Jun;24(3):483-91 PMID: 780021
  12. Neutralization of meningococcal endotoxin by antibody to core glycolipid.
    J Exp Med. 1978 Apr 1;147(4):1007-17 PMID: 418134
  13. Evaluation of survival in challenge experiments.
    Microbiol Rev. 1978 Mar;42(1):237-49 PMID: 752766
  14. Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2.
    Eur J Biochem. 1980;107(1):145-53 PMID: 6156828
  15. Size heterogeneity of Salmonella typhimurium lipopolysaccharides in outer membranes and culture supernatant membrane fragments.
    J Bacteriol. 1980 Nov;144(2):630-40 PMID: 7000751
  16. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.
    J Infect Dis. 1980 Oct;142(4):532-7 PMID: 6777436
  17. Toxicity of Haemophilus pleuropneumoniae for porcine lung macrophages, peripheral blood monocytes, and testicular cells.
    Infect Immun. 1981 Sep;33(3):673-6 PMID: 7287176
  18. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    J Clin Invest. 1982 Apr;69(4):742-9 PMID: 7042755
  19. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
    Surgery. 1982 Aug;92(2):212-9 PMID: 7048594
  20. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.
    N Engl J Med. 1982 Nov 11;307(20):1225-30 PMID: 6752708
  21. Prevalence of antibodies to Haemophilus pleuropneumoniae in Iowa swine.
    Am J Vet Res. 1982 Oct;43(10):1848-51 PMID: 7149390
  22. Dose response relationship of Haemophilus pleuropneumoniae aerosols in pigs.
    Can J Comp Med. 1983 Jan;47(1):54-6 PMID: 6219732
  23. The role of heparin in guinea pig gram negative bacterial sepsis.
    J Surg Res. 1983 May;34(5):479-85 PMID: 6405100
  24. Haemophilus pleuropneumoniae infection in swine: a review.
    J Am Vet Med Assoc. 1983 Jun 15;182(12):1331-7 PMID: 6348003
  25. Porcine Haemophilus pleuropneumonia: microbiologic and pathologic findings.
    J Am Vet Med Assoc. 1984 Mar 15;184(6):716-9 PMID: 6725106
  26. A 2-mercaptoethanol tube agglutination test for diagnosis of Haemophilus pleuropneumoniae infection in pigs.
    Am J Vet Res. 1984 Apr;45(4):715-9 PMID: 6731984
  27. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Infect Immun. 1984 Sep;45(3):631-6 PMID: 6381310
  28. Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria.
    Infect Immun. 1984 Dec;46(3):677-81 PMID: 6209222
  29. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.
    Am J Clin Pathol. 1961 Sep;36:212-9 PMID: 13738153
  30. Heparin therapy in septicemia with disseminated intravascular coagulation.
    N Engl J Med. 1970 Oct 8;283(15):778-82 PMID: 4989565
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1986-08-00
Pages
298-304
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC260874
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]